Effect of uricoqing granule on intestinal microflora of gout (spleen deficiency dampness resistance syndrome)
- Conditions
- gout
- Registration Number
- ITMCTR2100005395
- Lead Sponsor
- Yunnan Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
(1) It met the diagnostic criteria of primary gout and was in an intermittent period, and the syndrome was spleen deficiency and dampness resistance;(2) Aged between 18 and 65;(3) Did not take uric-lowering drugs, did not participate in clinical studies, or stopped eluting drugs for more than 6 months after participating in clinical studies;(4) No gastrointestinal diseases, antibiotics, gastrointestinal motility drugs or probiotics in the past 2 months;(5) Take the test voluntarily and sign the consent form.
(1) Secondary hyperuricemia caused by other diseases and treatment methods;(2) those who are using drugs that affect uric acid metabolism, such as salicylate, furosemide and thiazide diuretics;(3) those who have been allergic to the drug components used in this study, or are prone to allergic phenomenon;(4) Patients suffering from cardiovascular diseases or serious primary diseases of other organs and systems;(5) persons suffering from mental diseases;(6) women in pregnancy or lactation, or those who need to prepare for pregnancy;(7) overlap with other rheumatic diseases;(8) Those who plan to undergo surgery recently;(9) persons who are addicted to alcohol, drugs or drugs;(10) taking antibiotics, probiotics and prebiotics in the last two months;(12) Exclude metabolic diseases (especially those affecting the intestinal flora).
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method intestinal microflora;
- Secondary Outcome Measures
Name Time Method